Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIVERPEARL: FOLFOX6m + mAb with or without LIFEPEARLS-Irinotecan in Colorectal Cancer with Liver Metastases
NCT04595266Phase 2Active, not recruiting
- Sponsor
- GEMCAD
- Start
- Jun 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in colorectal cancer (CRC), liver metastasis, sponsored by GEMCAD. Started Jun 2021; status: active, not recruiting.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)liver metastasis
Beyond the preview
Go deeper on NCT04595266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04595266.